EPCORITAMAB-BYSP for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 64 adverse event reports in the FDA FAERS database where EPCORITAMAB-BYSP was used for Product used for unknown indication.
Most Reported Side Effects for EPCORITAMAB-BYSP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 369 | 37.7% | 136 | 87 |
| Diffuse large b-cell lymphoma | 206 | 21.1% | 112 | 25 |
| Diffuse large b-cell lymphoma refractory | 198 | 20.3% | 101 | 25 |
| Pyrexia | 79 | 8.1% | 29 | 26 |
| Immune effector cell-associated neurotoxicity syndrome | 77 | 7.9% | 34 | 28 |
| Covid-19 | 39 | 4.0% | 18 | 18 |
| Neutrophil count decreased | 35 | 3.6% | 11 | 12 |
| Hypogammaglobulinaemia | 32 | 3.3% | 7 | 8 |
| Platelet count decreased | 32 | 3.3% | 11 | 11 |
| Cytomegalovirus infection | 31 | 3.2% | 10 | 12 |
| Pneumonia | 29 | 3.0% | 16 | 13 |
| Cytomegalovirus infection reactivation | 26 | 2.7% | 7 | 5 |
| Death | 25 | 2.6% | 25 | 4 |
| Malignant neoplasm progression | 24 | 2.5% | 10 | 1 |
| Hypoalbuminaemia | 20 | 2.0% | 8 | 4 |
Other Indications for EPCORITAMAB-BYSP
Diffuse large b-cell lymphoma (362)
Diffuse large b-cell lymphoma refractory (353)
Diffuse large b-cell lymphoma recurrent (26)
Follicular lymphoma (19)
B-cell lymphoma (16)
B-cell lymphoma refractory (15)
Follicular lymphoma refractory (12)
High-grade b-cell lymphoma (10)
Lymphoma (7)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)